Primary breast carcinoma with neuroendocrine features is an extremely rare and underrecognized subtype of the breast carcinoma. And up to present, its biologic behavior, the most effective treatment, and prognosis are not well recognized. To diagnose this rare entity, special tumor stains of neuroendocrine markers are required, which are not routinely used. The imaging features of primary breast carcinoma with neuroendocrine features (BCNF) have not been accurately described due to the extreme rarity of this tumor type. We report the imaging features in a case of BCNF, with imaging findings different from the typical imaging findings of invasive breast carcinoma.
INTRODUCTION
Breast carcinoma is a heterogeneous disease, composed of many different subtypes with varying clinical characteristics. Neuroendocrine carcinoma is derived from neuroendocrine cells that are present throughout the body and arises most commonly from the bronchopulmonary system and gastrointestinal tract. Primary neuroendocrine carcinoma of the breast is a distinct subtype, first recognized by the World Health Organiza-This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted non-commercial use, distri-bution, and reproduction in any medium, provided the original work is properly cited. (2) . Although there are some published reports regarding this rare pathological entity, only a few reports include its imaging characteristics (3-7).
ORCID iDs
We report the imaging features in a case of primary BCNF (solid neuroendocrine carcinoma). 
CASE REPORT
A 47-year-old woman presented with a palpable lump in her left breast, which she had de- Neither of the imaging modalities showed any evidence of lymphadenopathy in the axillae.
The mass was categorized as Breast Imaging Reporting and Data System category '4A' , with a low suspicion for malignancy. Since the patient was referred to our hospital from an external local clinic with the suspicion of breast cancer, she underwent surgery without preoperative US-guided core needle biopsy. During the operation, the frozen section diagnosis was of a malignant tumor, type deferred; hence, she underwent breast conservation surgery. Grossly, the tumor appeared as a well-demarcated, partly encapsulated, pinkish tan, soft and solid mass, measuring 2.5 × 2.2 cm. On the cut surface of the resected tumor, multifocal small cystic spaces were noted, whereas pathologically, there was no evidence of metastatic lymphadenopathy. Histopathologically, the tumor consisted of cellular nests and trabeculae of tumor cells, revealing spindle to ovoid cells in rosette formation (Fig. 1D) . Immunohistochemi- receptor, and progesterone receptor (Fig. 1E) . Based on these pathologic findings, we considered this tumor to be a solid neuroendocrine carcinoma. PET-CT showed the absence of an abnormal uptake, suggesting that the breast was the only primary site. Annual follow-up breast US and mammography were performed for 7 years and PET-CT was performed annually or bi-annually for 4 years, showing no evidence of local recurrence or distant metastasis.
DISCUSSION
Primary BCNF is an underrecognized and extremely rare subtype of breast carcinomas, accounting for 0.27% to 0.5% of histopathologically proven breast cancers (8) . Currently, its biologic behavior, most effective treatment, and prognosis are not well recognized. Although no consensus has been reached on the prognosis, large-scale population studies have shown poor outcomes as compared to invasive breast carcinomas (8, 9).
There are 2 main theories on the histogenesis of primary BCNF (10). The first, which is more controversial, is that these tumors evolve from neoplastic transformation of native endocrine cells. However, the more accepted theory is that neuroendocrine differentiation aris- There are a few reports that described the imaging features of primary BCNF (4-7). The results of those studies suggest that the mammographic findings of primary BCNF differ from typical findings of invasive breast carcinomas, which tend to be irregular in shape with spec- Meanwhile, large-scale population studies about primary BCNF suggest that it has a poor prognosis with a higher rate of local and distant recurrence, compared to invasive breast carcinomas (8, 9) . In contrast, our patient had a relatively good prognosis for up to 7 years after breast conservation surgery, with follow-up studies (mammography, breast US, and PET-CT) revealing no evidence of local recurrence or distant metastasis, even without postoperative chemotherapy and radiotherapy.
In this report, we present a case of primary BCNF (solid neuroendocrine carcinoma) of the breast, together with its mammographic and sonographic features. More reports of new cases will be necessary in order to describe the imaging features of primary BCNF. Furthermore, more reports regarding the treatment and prognosis of this entity will help develop the most effective treatment plan.
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